"Chemokine CXCL1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types.
| Descriptor ID |
D054360
|
| MeSH Number(s) |
D12.644.276.374.200.120.050 D12.776.467.374.200.120.050 D12.776.624.664.700.049 D23.125.300.120.050 D23.469.200.120.050 D23.529.374.200.120.050
|
| Concept/Terms |
Chemokine CXCL1- Chemokine CXCL1
- CXCL1, Chemokine
- CXCL1 Chemokine
- Chemokine, CXCL1
- Gro-alpha Protein
- Gro alpha Protein
- GROalpha Protein
- Melanoma Growth Stimulatory Activity, alpha Protein
- MGSA-alpha Chemokine
- Chemokine, MGSA-alpha
- MGSA alpha Chemokine
- Neutrophil-Activating Protein 3
- Neutrophil Activating Protein 3
- Chemokine (C-X-C Motif) Ligand 1
- Growth-Related Oncogene alpha Protein
- Growth Related Oncogene alpha Protein
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL1".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL1".
This graph shows the total number of publications written about "Chemokine CXCL1" by people in this website by year, and whether "Chemokine CXCL1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 3 | 3 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 2 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL1" by people in Profiles.
-
MicroRNA-206 antagomiR?enriched extracellular vesicles attenuate lung ischemia?reperfusion injury through CXCL1 regulation in alveolar epithelial cells. J Heart Lung Transplant. 2020 12; 39(12):1476-1490.
-
The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation. J Crohns Colitis. 2018 Feb 28; 12(3):355-368.
-
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. Cancer Res. 2017 07 01; 77(13):3655-3665.
-
Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis. Prostaglandins Other Lipid Mediat. 2017 05; 130:47-56.
-
Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Oncogene. 2016 08 04; 35(31):4036-47.
-
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor ? in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. J Immunol. 2015 Jun 01; 194(11):5211-22.
-
Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2. Cytokine. 2015 Jan; 71(1):71-80.
-
CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013 Nov 11; 24(5):631-44.
-
Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes. 2006 Sep; 55(9):2579-87.
-
Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum. 2006 Jul; 54(7):2198-210.